JP2009523812A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009523812A5 JP2009523812A5 JP2008551416A JP2008551416A JP2009523812A5 JP 2009523812 A5 JP2009523812 A5 JP 2009523812A5 JP 2008551416 A JP2008551416 A JP 2008551416A JP 2008551416 A JP2008551416 A JP 2008551416A JP 2009523812 A5 JP2009523812 A5 JP 2009523812A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrrolo
- pyridin
- alkyl
- benzyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 91
- 125000000304 alkynyl group Chemical group 0.000 claims 50
- 125000003342 alkenyl group Chemical group 0.000 claims 18
- 150000001875 compounds Chemical class 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 13
- 125000003545 alkoxy group Chemical group 0.000 claims 12
- 125000004414 alkyl thio group Chemical group 0.000 claims 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims 11
- 125000000623 heterocyclic group Chemical group 0.000 claims 11
- 125000003118 aryl group Chemical group 0.000 claims 10
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 8
- 125000005843 halogen group Chemical group 0.000 claims 8
- 125000001424 substituent group Chemical group 0.000 claims 8
- -1 R 22a Chemical compound 0.000 claims 7
- 125000004093 cyano group Chemical group *C#N 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000006620 amino-(C1-C6) alkyl group Chemical group 0.000 claims 3
- 239000002246 antineoplastic agent Substances 0.000 claims 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 101100516563 Caenorhabditis elegans nhr-6 gene Proteins 0.000 claims 2
- 206010014733 Endometrial cancer Diseases 0.000 claims 2
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 2
- 208000006265 Renal cell carcinoma Diseases 0.000 claims 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 2
- 239000012830 cancer therapeutic Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 230000003463 hyperproliferative effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- LSAAIXBCZXQBIF-AWEZNQCLSA-N (2s)-3,3-dimethyl-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]butan-2-amine Chemical compound C1=CC(CN[C@@H](C)C(C)(C)C)=CC=C1C1=CC=NC2=C1C=CN2 LSAAIXBCZXQBIF-AWEZNQCLSA-N 0.000 claims 1
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 claims 1
- MXHDTPHQKKJTFP-ONEGZZNKSA-N (e)-4-[4-(3-acetyl-1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]but-3-en-2-one Chemical compound C1=CC(/C=C/C(=O)C)=CC=C1C1=CC=NC2=C1C(C(C)=O)=CN2 MXHDTPHQKKJTFP-ONEGZZNKSA-N 0.000 claims 1
- RIBOCHYWSQMSPG-UHFFFAOYSA-N 1-(2-fluorophenyl)-3-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]urea Chemical compound FC1=CC=CC=C1NC(=O)NC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 RIBOCHYWSQMSPG-UHFFFAOYSA-N 0.000 claims 1
- JBOWFZLIHYJIJV-UHFFFAOYSA-N 1-(2-fluorophenyl)-n-[[5-(1h-pyrrolo[2,3-b]pyridin-4-yl)thiophen-2-yl]methyl]methanamine Chemical compound FC1=CC=CC=C1CNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)S1 JBOWFZLIHYJIJV-UHFFFAOYSA-N 0.000 claims 1
- XCZIUZRMJVRXAO-UHFFFAOYSA-N 1-(3-fluorophenyl)-3-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]urea Chemical compound FC1=CC=CC(NC(=O)NC=2C=CC(=CC=2)C=2C=3C=CNC=3N=CC=2)=C1 XCZIUZRMJVRXAO-UHFFFAOYSA-N 0.000 claims 1
- SHYZHDIDMSOIML-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]urea Chemical compound C1=CC(F)=CC=C1NC(=O)NC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 SHYZHDIDMSOIML-UHFFFAOYSA-N 0.000 claims 1
- WHYZTAZVBTUCOH-UHFFFAOYSA-N 1-(4-methylphenyl)-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]methanamine Chemical compound C1=CC(C)=CC=C1CNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 WHYZTAZVBTUCOH-UHFFFAOYSA-N 0.000 claims 1
- HVTOEFSLOQHZTL-UHFFFAOYSA-N 1-(4-naphthalen-2-yl-1h-pyrrolo[2,3-b]pyridin-3-yl)ethanone Chemical compound C1=CC=CC2=CC(C=3C=CN=C4NC=C(C=34)C(=O)C)=CC=C21 HVTOEFSLOQHZTL-UHFFFAOYSA-N 0.000 claims 1
- FKGARMNFEGUUFP-UHFFFAOYSA-N 1-(4-phenyl-1h-pyrrolo[2,3-b]pyridin-3-yl)ethanone Chemical compound C=12C(C(=O)C)=CNC2=NC=CC=1C1=CC=CC=C1 FKGARMNFEGUUFP-UHFFFAOYSA-N 0.000 claims 1
- WWYLDLGCYXVKMB-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-3-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]urea Chemical compound FC1=CC=CC=C1CNC(=O)NC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 WWYLDLGCYXVKMB-UHFFFAOYSA-N 0.000 claims 1
- QBRLCNKHXUBHAE-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-3-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]urea Chemical compound FC1=CC=CC(CNC(=O)NC=2C=CC(=CC=2)C=2C=3C=CNC=3N=CC=2)=C1 QBRLCNKHXUBHAE-UHFFFAOYSA-N 0.000 claims 1
- HRYWBCMSSNOADX-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]-3-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]urea Chemical compound C1=CC(F)=CC=C1CNC(=O)NC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 HRYWBCMSSNOADX-UHFFFAOYSA-N 0.000 claims 1
- YPFPNZZYSFPALS-UHFFFAOYSA-N 1-[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 YPFPNZZYSFPALS-UHFFFAOYSA-N 0.000 claims 1
- NMSLZKLSGJOACM-UHFFFAOYSA-N 1-[3-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methylamino]phenyl]ethanol Chemical compound CC(O)C1=CC=CC(NCC=2C=C(C=CC=2)C=2C=3C=CNC=3N=CC=2)=C1 NMSLZKLSGJOACM-UHFFFAOYSA-N 0.000 claims 1
- DHOBCFVLDNCPTP-UHFFFAOYSA-N 1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]-n-(thiophen-2-ylmethyl)methanamine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CNCC1=CC=CS1 DHOBCFVLDNCPTP-UHFFFAOYSA-N 0.000 claims 1
- GAWDCFGDCVYXBM-UHFFFAOYSA-N 1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]-n-[[4-(trifluoromethyl)phenyl]methyl]methanamine Chemical compound C1=CC(C(F)(F)F)=CC=C1CNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 GAWDCFGDCVYXBM-UHFFFAOYSA-N 0.000 claims 1
- LLUCABACISDVEJ-UHFFFAOYSA-N 1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]ethanol Chemical compound C1=CC(C(O)C)=CC=C1C1=CC=NC2=C1C=CN2 LLUCABACISDVEJ-UHFFFAOYSA-N 0.000 claims 1
- DKMSFKYTBAROMV-UHFFFAOYSA-N 1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1C1=CC=NC2=C1C=CN2 DKMSFKYTBAROMV-UHFFFAOYSA-N 0.000 claims 1
- IFKSPAFRVINCAT-UHFFFAOYSA-N 1-[4-(3-acetyl-1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]ethanone Chemical compound C=12C(C(=O)C)=CNC2=NC=CC=1C1=CC=C(C(C)=O)C=C1 IFKSPAFRVINCAT-UHFFFAOYSA-N 0.000 claims 1
- HUXNFPXNPZRJJH-UHFFFAOYSA-N 1-[4-(3-bromo-1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1C1=CC=NC2=C1C(Br)=CN2 HUXNFPXNPZRJJH-UHFFFAOYSA-N 0.000 claims 1
- HSZBXOYNPSAUKY-UHFFFAOYSA-N 1-[4-(3-chloro-1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1C1=CC=NC2=C1C(Cl)=CN2 HSZBXOYNPSAUKY-UHFFFAOYSA-N 0.000 claims 1
- KAPNVDSMXCLCAD-UHFFFAOYSA-N 1-[4-(3-fluorophenyl)-1h-pyrrolo[2,3-b]pyridin-3-yl]ethanone Chemical compound C=12C(C(=O)C)=CNC2=NC=CC=1C1=CC=CC(F)=C1 KAPNVDSMXCLCAD-UHFFFAOYSA-N 0.000 claims 1
- CISPXNYVLLQSNH-UHFFFAOYSA-N 1-[5-(1h-pyrrolo[2,3-b]pyridin-4-yl)thiophen-2-yl]ethanone Chemical compound S1C(C(=O)C)=CC=C1C1=CC=NC2=C1C=CN2 CISPXNYVLLQSNH-UHFFFAOYSA-N 0.000 claims 1
- LCVHPHMVSRORGH-UHFFFAOYSA-N 1-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]piperidine-3-carboxamide Chemical compound C1C(C(=O)N)CCCN1CC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 LCVHPHMVSRORGH-UHFFFAOYSA-N 0.000 claims 1
- XYBBXNCSGCKWCF-UHFFFAOYSA-N 1-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]piperidin-3-ol Chemical compound C1C(O)CCCN1CC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 XYBBXNCSGCKWCF-UHFFFAOYSA-N 0.000 claims 1
- MSAXTWFJXYJJPF-UHFFFAOYSA-N 1-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]piperidin-4-ol Chemical compound C1CC(O)CCN1CC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 MSAXTWFJXYJJPF-UHFFFAOYSA-N 0.000 claims 1
- CGNCOVJZQRWUQN-UHFFFAOYSA-N 1-benzyl-3-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]urea Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1NC(=O)NCC1=CC=CC=C1 CGNCOVJZQRWUQN-UHFFFAOYSA-N 0.000 claims 1
- LEADQZKZEFERGP-UHFFFAOYSA-N 1-phenyl-3-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]urea Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1NC(=O)NC1=CC=CC=C1 LEADQZKZEFERGP-UHFFFAOYSA-N 0.000 claims 1
- BOICEQGQSYCYMH-UHFFFAOYSA-N 1-phenyl-n-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]ethanamine Chemical compound C=1C=CC(C=2C=3C=CNC=3N=CC=2)=CC=1CNC(C)C1=CC=CC=C1 BOICEQGQSYCYMH-UHFFFAOYSA-N 0.000 claims 1
- MSYBXEOBAGBLFM-UHFFFAOYSA-N 1-phenyl-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]ethanamine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CNC(C)C1=CC=CC=C1 MSYBXEOBAGBLFM-UHFFFAOYSA-N 0.000 claims 1
- AOALFLLKUJAMFJ-UHFFFAOYSA-N 1-phenyl-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]methanamine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CNCC1=CC=CC=C1 AOALFLLKUJAMFJ-UHFFFAOYSA-N 0.000 claims 1
- LVRUNIIPCOTYHD-UHFFFAOYSA-N 2-(2-fluorophenyl)-n-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]acetamide Chemical compound FC1=CC=CC=C1CC(=O)NC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 LVRUNIIPCOTYHD-UHFFFAOYSA-N 0.000 claims 1
- SXIWZYNHPANAFR-UHFFFAOYSA-N 2-(3-fluorophenyl)-n-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]acetamide Chemical compound FC1=CC=CC(CC(=O)NC=2C=CC(=CC=2)C=2C=3C=CNC=3N=CC=2)=C1 SXIWZYNHPANAFR-UHFFFAOYSA-N 0.000 claims 1
- NHHCELHSUFIGDY-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]acetamide Chemical compound C1=CC(F)=CC=C1CC(=O)NC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 NHHCELHSUFIGDY-UHFFFAOYSA-N 0.000 claims 1
- NMSIBJORXPUOKW-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]ethanamine Chemical compound C1=CC(F)=CC=C1CCNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 NMSIBJORXPUOKW-UHFFFAOYSA-N 0.000 claims 1
- VZLDENCJUJTIHH-UHFFFAOYSA-N 2-(diethylamino)ethyl 4-[[5-(1h-pyrrolo[2,3-b]pyridin-4-yl)thiophen-2-yl]methylamino]benzoate Chemical compound C1=CC(C(=O)OCCN(CC)CC)=CC=C1NCC1=CC=C(C=2C=3C=CNC=3N=CC=2)S1 VZLDENCJUJTIHH-UHFFFAOYSA-N 0.000 claims 1
- ZNUDSRAYSAUSTH-UHFFFAOYSA-N 2-[4-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]piperazin-1-yl]ethanol Chemical compound C1CN(CCO)CCN1CC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 ZNUDSRAYSAUSTH-UHFFFAOYSA-N 0.000 claims 1
- YUVNZXDNPNDKBN-UHFFFAOYSA-N 2-[4-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methylamino]phenyl]ethanol Chemical compound C1=CC(CCO)=CC=C1NCC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 YUVNZXDNPNDKBN-UHFFFAOYSA-N 0.000 claims 1
- GUMSTTBZAFRUKD-UHFFFAOYSA-N 2-[4-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]piperazin-1-yl]ethanol Chemical compound C1CN(CCO)CCN1CC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 GUMSTTBZAFRUKD-UHFFFAOYSA-N 0.000 claims 1
- YVHWYZNRVTVJDU-UHFFFAOYSA-N 2-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]-3,4-dihydro-1h-isoquinoline Chemical compound C1CC2=CC=CC=C2CN1CC(C=C1)=CC=C1C1=CC=NC2=C1C=CN2 YVHWYZNRVTVJDU-UHFFFAOYSA-N 0.000 claims 1
- LNGQWTMTMCADTF-UHFFFAOYSA-N 2-[[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methylamino]methyl]cyclohexan-1-ol Chemical compound OC1CCCCC1CNCC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 LNGQWTMTMCADTF-UHFFFAOYSA-N 0.000 claims 1
- UQRXSSFJRSKQRP-UHFFFAOYSA-N 2-[[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methylamino]methyl]cyclohexan-1-ol Chemical compound OC1CCCCC1CNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 UQRXSSFJRSKQRP-UHFFFAOYSA-N 0.000 claims 1
- QRDPXMWBRFYGCJ-UHFFFAOYSA-N 2-[butyl-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]amino]ethanol Chemical compound C1=CC(CN(CCO)CCCC)=CC=C1C1=CC=NC2=C1C=CN2 QRDPXMWBRFYGCJ-UHFFFAOYSA-N 0.000 claims 1
- BNRZNIOJUKNFIO-UHFFFAOYSA-N 2-methoxy-n-(2-methoxyethyl)-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]ethanamine Chemical compound C1=CC(CN(CCOC)CCOC)=CC=C1C1=CC=NC2=C1C=CN2 BNRZNIOJUKNFIO-UHFFFAOYSA-N 0.000 claims 1
- ARECOFLAJIWPKR-UHFFFAOYSA-N 2-methoxy-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]ethanamine Chemical compound C1=CC(CNCCOC)=CC=C1C1=CC=NC2=C1C=CN2 ARECOFLAJIWPKR-UHFFFAOYSA-N 0.000 claims 1
- CDPVVKRHEHNESI-UHFFFAOYSA-N 2-methyl-3-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methylamino]phenol Chemical compound CC1=C(O)C=CC=C1NCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 CDPVVKRHEHNESI-UHFFFAOYSA-N 0.000 claims 1
- XDQIWAHXYZZLKB-UHFFFAOYSA-N 2-phenyl-n-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]acetamide Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1NC(=O)CC1=CC=CC=C1 XDQIWAHXYZZLKB-UHFFFAOYSA-N 0.000 claims 1
- RGBVBBZZZQWGOJ-UHFFFAOYSA-N 2-phenyl-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]acetamide Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CNC(=O)CC1=CC=CC=C1 RGBVBBZZZQWGOJ-UHFFFAOYSA-N 0.000 claims 1
- AOGGPHNNNOAVJW-UHFFFAOYSA-N 2-phenyl-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]propan-2-amine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CNC(C)(C)C1=CC=CC=C1 AOGGPHNNNOAVJW-UHFFFAOYSA-N 0.000 claims 1
- BKCYYMMFJAYTHP-UHFFFAOYSA-N 2-pyridin-2-yl-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]ethanamine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CNCCC1=CC=CC=N1 BKCYYMMFJAYTHP-UHFFFAOYSA-N 0.000 claims 1
- VOPHLJYKEMJYCJ-UHFFFAOYSA-N 2-pyrrolidin-1-yl-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]ethanamine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CNCCN1CCCC1 VOPHLJYKEMJYCJ-UHFFFAOYSA-N 0.000 claims 1
- GYMVBQOXLVVBRX-UHFFFAOYSA-N 3-(4-methylpiperazin-1-yl)-n-[[5-(1h-pyrrolo[2,3-b]pyridin-4-yl)furan-2-yl]methyl]propan-1-amine Chemical compound C1CN(C)CCN1CCCNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)O1 GYMVBQOXLVVBRX-UHFFFAOYSA-N 0.000 claims 1
- GAHIWVXJAFVSCV-UHFFFAOYSA-N 3-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methylamino]benzamide Chemical compound NC(=O)C1=CC=CC(NCC=2C=C(C=CC=2)C=2C=3C=CNC=3N=CC=2)=C1 GAHIWVXJAFVSCV-UHFFFAOYSA-N 0.000 claims 1
- ZASNOVPELXAJLV-UHFFFAOYSA-N 3-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methylamino]benzoic acid Chemical compound OC(=O)C1=CC=CC(NCC=2C=CC(=CC=2)C=2C=3C=CNC=3N=CC=2)=C1 ZASNOVPELXAJLV-UHFFFAOYSA-N 0.000 claims 1
- QGMZIRDBBIYJKQ-UHFFFAOYSA-N 3-[[5-(1h-pyrrolo[2,3-b]pyridin-4-yl)thiophen-2-yl]methylamino]benzamide Chemical compound NC(=O)C1=CC=CC(NCC=2SC(=CC=2)C=2C=3C=CNC=3N=CC=2)=C1 QGMZIRDBBIYJKQ-UHFFFAOYSA-N 0.000 claims 1
- OSDTVFJKHNSQMM-UHFFFAOYSA-N 3-amino-n-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]propanamide Chemical compound NCCC(=O)NCC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 OSDTVFJKHNSQMM-UHFFFAOYSA-N 0.000 claims 1
- LWHMRDLIGBHBKL-UHFFFAOYSA-N 3-bromo-4-(4-ethenylphenyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound C=12C(Br)=CNC2=NC=CC=1C1=CC=C(C=C)C=C1 LWHMRDLIGBHBKL-UHFFFAOYSA-N 0.000 claims 1
- ZSMRIWSMVPTAQV-UHFFFAOYSA-N 3-bromo-4-(4-phenylphenyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound C=12C(Br)=CNC2=NC=CC=1C(C=C1)=CC=C1C1=CC=CC=C1 ZSMRIWSMVPTAQV-UHFFFAOYSA-N 0.000 claims 1
- IQIMIVGEUAMPKB-UHFFFAOYSA-N 3-bromo-4-phenyl-1h-pyrrolo[2,3-b]pyridine Chemical compound C=12C(Br)=CNC2=NC=CC=1C1=CC=CC=C1 IQIMIVGEUAMPKB-UHFFFAOYSA-N 0.000 claims 1
- POSMXMUTMPXPSP-UHFFFAOYSA-N 3-chloro-4-phenyl-1h-pyrrolo[2,3-b]pyridine Chemical compound C=12C(Cl)=CNC2=NC=CC=1C1=CC=CC=C1 POSMXMUTMPXPSP-UHFFFAOYSA-N 0.000 claims 1
- JFMCRNSHLWKUIY-UHFFFAOYSA-N 4-(1,3-benzodioxol-5-yl)-3-bromo-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=C2OCOC2=CC(C=2C=CN=C3NC=C(C=23)Br)=C1 JFMCRNSHLWKUIY-UHFFFAOYSA-N 0.000 claims 1
- VHEJPBSPTWRNPT-UHFFFAOYSA-N 4-(1,3-benzodioxol-5-yl)-3-chloro-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=C2OCOC2=CC(C=2C=CN=C3NC=C(C=23)Cl)=C1 VHEJPBSPTWRNPT-UHFFFAOYSA-N 0.000 claims 1
- FLDSBYWZXRKWLE-UHFFFAOYSA-N 4-(1H-pyrrolo[2,3-b]pyridin-4-yl)phenol Chemical compound C1=CC(O)=CC=C1C1=CC=NC2=C1C=CN2 FLDSBYWZXRKWLE-UHFFFAOYSA-N 0.000 claims 1
- FFILGYUMCLBXEU-UHFFFAOYSA-N 4-(1h-pyrrolo[2,3-b]pyridin-4-yl)aniline Chemical compound C1=CC(N)=CC=C1C1=CC=NC2=C1C=CN2 FFILGYUMCLBXEU-UHFFFAOYSA-N 0.000 claims 1
- FJPFKKDTDZRSIR-UHFFFAOYSA-N 4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C1=CC(C(=O)N)=CC=C1C1=CC=NC2=C1C=CN2 FJPFKKDTDZRSIR-UHFFFAOYSA-N 0.000 claims 1
- FVITYDQZVVVEBX-UHFFFAOYSA-N 4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzonitrile Chemical compound C1=CC(C#N)=CC=C1C1=CC=NC2=C1C=CN2 FVITYDQZVVVEBX-UHFFFAOYSA-N 0.000 claims 1
- VKUDIDBKHUOMJX-UHFFFAOYSA-N 4-(2,3-difluorophenyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound FC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1F VKUDIDBKHUOMJX-UHFFFAOYSA-N 0.000 claims 1
- XYLGZPKYLLYTBI-UHFFFAOYSA-N 4-(2-chlorophenyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound ClC1=CC=CC=C1C1=CC=NC2=C1C=CN2 XYLGZPKYLLYTBI-UHFFFAOYSA-N 0.000 claims 1
- QHWSVRLUWHOMMO-UHFFFAOYSA-N 4-(2-fluoro-3-methoxyphenyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound COC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1F QHWSVRLUWHOMMO-UHFFFAOYSA-N 0.000 claims 1
- ZEBGHGKFEHDRKK-UHFFFAOYSA-N 4-(2-fluorophenyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound FC1=CC=CC=C1C1=CC=NC2=C1C=CN2 ZEBGHGKFEHDRKK-UHFFFAOYSA-N 0.000 claims 1
- SZLYEAYUTZPHRC-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC=NC2=C1C=CN2 SZLYEAYUTZPHRC-UHFFFAOYSA-N 0.000 claims 1
- ULJVNBXYQQUMQH-UHFFFAOYSA-N 4-(3,5-difluorophenyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound FC1=CC(F)=CC(C=2C=3C=CNC=3N=CC=2)=C1 ULJVNBXYQQUMQH-UHFFFAOYSA-N 0.000 claims 1
- JMSMESSLISOXTQ-UHFFFAOYSA-N 4-(3-fluorophenyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound FC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 JMSMESSLISOXTQ-UHFFFAOYSA-N 0.000 claims 1
- FESCLNQCQNCYCH-UHFFFAOYSA-N 4-(3-methylphenyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound CC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 FESCLNQCQNCYCH-UHFFFAOYSA-N 0.000 claims 1
- JNKPFYGHHWTGQG-UHFFFAOYSA-N 4-(4-methylphenyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=CC(C)=CC=C1C1=CC=NC2=C1C=CN2 JNKPFYGHHWTGQG-UHFFFAOYSA-N 0.000 claims 1
- IPVPLZZKAYTKDX-UHFFFAOYSA-N 4-(4-methylsulfonylphenyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CC=NC2=C1C=CN2 IPVPLZZKAYTKDX-UHFFFAOYSA-N 0.000 claims 1
- VZPVFFCEJNTVAS-UHFFFAOYSA-N 4-(5-methylthiophen-2-yl)-1h-pyrrolo[2,3-b]pyridine Chemical compound S1C(C)=CC=C1C1=CC=NC2=C1C=CN2 VZPVFFCEJNTVAS-UHFFFAOYSA-N 0.000 claims 1
- GVYFSHAWVJRXBJ-UHFFFAOYSA-N 4-(6-methoxypyridin-2-yl)-1h-pyrrolo[2,3-b]pyridine Chemical compound COC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=N1 GVYFSHAWVJRXBJ-UHFFFAOYSA-N 0.000 claims 1
- XOGQFWTZDVSSSQ-UHFFFAOYSA-N 4-(6-methoxypyridin-3-yl)-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=NC(OC)=CC=C1C1=CC=NC2=C1C=CN2 XOGQFWTZDVSSSQ-UHFFFAOYSA-N 0.000 claims 1
- JEGODMCUQQRKDA-UHFFFAOYSA-N 4-[4-(1,3-dihydroisoindol-2-ylmethyl)phenyl]-1h-pyrrolo[2,3-b]pyridine Chemical compound C1C2=CC=CC=C2CN1CC(C=C1)=CC=C1C1=CC=NC2=C1C=CN2 JEGODMCUQQRKDA-UHFFFAOYSA-N 0.000 claims 1
- CGTOIZSPVAUDGG-UHFFFAOYSA-N 4-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]morpholine Chemical compound C1COCCN1C1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 CGTOIZSPVAUDGG-UHFFFAOYSA-N 0.000 claims 1
- SCSSKDSFSMVAFM-UHFFFAOYSA-N 4-[4-(3-thiophen-2-yl-1h-pyrazol-5-yl)piperidin-1-yl]-1h-pyrrolo[2,3-b]pyridine Chemical compound C1CN(C=2C=3C=CNC=3N=CC=2)CCC1C(=NN1)C=C1C1=CC=CS1 SCSSKDSFSMVAFM-UHFFFAOYSA-N 0.000 claims 1
- VYEQAVBDBQIUCM-UHFFFAOYSA-N 4-[4-(azocan-1-ylmethyl)phenyl]-1h-pyrrolo[2,3-b]pyridine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CN1CCCCCCC1 VYEQAVBDBQIUCM-UHFFFAOYSA-N 0.000 claims 1
- KAWDWMNGQTVNLF-UHFFFAOYSA-N 4-[4-(piperidin-1-ylmethyl)phenyl]-1h-pyrrolo[2,3-b]pyridine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CN1CCCCC1 KAWDWMNGQTVNLF-UHFFFAOYSA-N 0.000 claims 1
- OYXIMFPCANLVPE-UHFFFAOYSA-N 4-[4-(pyrrolidin-1-ylmethyl)phenyl]-1h-pyrrolo[2,3-b]pyridine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CN1CCCC1 OYXIMFPCANLVPE-UHFFFAOYSA-N 0.000 claims 1
- LFWHTAIHAOWRLD-UHFFFAOYSA-N 4-[4-[(4-butylpiperazin-1-yl)methyl]phenyl]-1h-pyrrolo[2,3-b]pyridine Chemical compound C1CN(CCCC)CCN1CC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 LFWHTAIHAOWRLD-UHFFFAOYSA-N 0.000 claims 1
- WAZLMVMZVFZZFF-UHFFFAOYSA-N 4-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-1h-pyrrolo[2,3-b]pyridine Chemical compound C1CN(C)CCN1CC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 WAZLMVMZVFZZFF-UHFFFAOYSA-N 0.000 claims 1
- QDNGSCNJIAJSFC-UHFFFAOYSA-N 4-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methylamino]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1NCC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 QDNGSCNJIAJSFC-UHFFFAOYSA-N 0.000 claims 1
- QDOHSHGYFXWVTK-UHFFFAOYSA-N 4-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]morpholine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CN1CCOCC1 QDOHSHGYFXWVTK-UHFFFAOYSA-N 0.000 claims 1
- UDWJQLYKDBQOSU-UHFFFAOYSA-N 4-[[5-(1h-pyrrolo[2,3-b]pyridin-4-yl)thiophen-2-yl]methylamino]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1NCC1=CC=C(C=2C=3C=CNC=3N=CC=2)S1 UDWJQLYKDBQOSU-UHFFFAOYSA-N 0.000 claims 1
- CZIVYQYQBGEICQ-UHFFFAOYSA-N 4-fluoro-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]aniline Chemical compound C1=CC(F)=CC=C1NCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 CZIVYQYQBGEICQ-UHFFFAOYSA-N 0.000 claims 1
- UMUDVCMVNRZSQD-UHFFFAOYSA-N 4-pyridin-4-yl-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=CN=C2NC=CC2=C1C1=CC=NC=C1 UMUDVCMVNRZSQD-UHFFFAOYSA-N 0.000 claims 1
- HEOFKLHYVBEXQI-UHFFFAOYSA-N 4-thiophen-2-yl-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=CSC(C=2C=3C=CNC=3N=CC=2)=C1 HEOFKLHYVBEXQI-UHFFFAOYSA-N 0.000 claims 1
- JZLJKFICWUITIH-UHFFFAOYSA-N 4-thiophen-3-yl-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=CN=C2NC=CC2=C1C=1C=CSC=1 JZLJKFICWUITIH-UHFFFAOYSA-N 0.000 claims 1
- MTYPWZYLDFQFJV-UHFFFAOYSA-N 5-(1h-pyrrolo[2,3-b]pyridin-4-yl)furan-2-carbaldehyde Chemical compound O1C(C=O)=CC=C1C1=CC=NC2=C1C=CN2 MTYPWZYLDFQFJV-UHFFFAOYSA-N 0.000 claims 1
- PTWLKRUDCQZPDA-UHFFFAOYSA-N 5-cyclopropyl-2-methyl-n-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]pyrazol-3-amine Chemical compound C1=C(NCC=2C=C(C=CC=2)C=2C=3C=CNC=3N=CC=2)N(C)N=C1C1CC1 PTWLKRUDCQZPDA-UHFFFAOYSA-N 0.000 claims 1
- BJKGGGHDZRCTJK-UHFFFAOYSA-N 5-cyclopropyl-2-methyl-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]pyrazol-3-amine Chemical compound C1=C(NCC=2C=CC(=CC=2)C=2C=3C=CNC=3N=CC=2)N(C)N=C1C1CC1 BJKGGGHDZRCTJK-UHFFFAOYSA-N 0.000 claims 1
- MFWOPNQACIXWPK-UHFFFAOYSA-N 5-ethyl-n-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]-1,3,4-thiadiazol-2-amine Chemical compound S1C(CC)=NN=C1NCC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 MFWOPNQACIXWPK-UHFFFAOYSA-N 0.000 claims 1
- KFVWUJXAKVGIJL-UHFFFAOYSA-N 5-methyl-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]pyridin-2-amine Chemical compound N1=CC(C)=CC=C1NCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 KFVWUJXAKVGIJL-UHFFFAOYSA-N 0.000 claims 1
- YCBGCXPADKZDJG-UHFFFAOYSA-N 6-methyl-n-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]pyridin-2-amine Chemical compound CC1=CC=CC(NCC=2C=C(C=CC=2)C=2C=3C=CNC=3N=CC=2)=N1 YCBGCXPADKZDJG-UHFFFAOYSA-N 0.000 claims 1
- NIFUCOMMAYCLPX-UHFFFAOYSA-N 6-methyl-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]pyridin-2-amine Chemical compound CC1=CC=CC(NCC=2C=CC(=CC=2)C=2C=3C=CNC=3N=CC=2)=N1 NIFUCOMMAYCLPX-UHFFFAOYSA-N 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims 1
- 208000002927 Hamartoma Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 208000025205 Mantle-Cell Lymphoma Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- HLQVULNQEAUHCD-UHFFFAOYSA-N [3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound NCC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 HLQVULNQEAUHCD-UHFFFAOYSA-N 0.000 claims 1
- SFPIINLBMLIHMY-UHFFFAOYSA-N [3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanol Chemical compound OCC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 SFPIINLBMLIHMY-UHFFFAOYSA-N 0.000 claims 1
- COICVXBUXIFHOM-UHFFFAOYSA-N [3-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methylamino]phenyl]methanol Chemical compound OCC1=CC=CC(NCC=2C=C(C=CC=2)C=2C=3C=CNC=3N=CC=2)=C1 COICVXBUXIFHOM-UHFFFAOYSA-N 0.000 claims 1
- VJGPPGQUFNKDHH-UHFFFAOYSA-N [3-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methylamino]phenyl]methanol Chemical compound OCC1=CC=CC(NCC=2C=CC(=CC=2)C=2C=3C=CNC=3N=CC=2)=C1 VJGPPGQUFNKDHH-UHFFFAOYSA-N 0.000 claims 1
- ALPPLOWFWATXSQ-UHFFFAOYSA-N [4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound C1=CC(CN)=CC=C1C1=CC=NC2=C1C=CN2 ALPPLOWFWATXSQ-UHFFFAOYSA-N 0.000 claims 1
- HVCZPJKYIPYOLB-UHFFFAOYSA-N [4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanol Chemical compound C1=CC(CO)=CC=C1C1=CC=NC2=C1C=CN2 HVCZPJKYIPYOLB-UHFFFAOYSA-N 0.000 claims 1
- 125000005090 alkenylcarbonyl group Chemical group 0.000 claims 1
- 125000002877 alkyl aryl group Chemical group 0.000 claims 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 125000005087 alkynylcarbonyl group Chemical group 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 239000004037 angiogenesis inhibitor Substances 0.000 claims 1
- 230000001772 anti-angiogenic effect Effects 0.000 claims 1
- 230000000118 anti-neoplastic effect Effects 0.000 claims 1
- 230000000259 anti-tumor effect Effects 0.000 claims 1
- 229940034982 antineoplastic agent Drugs 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000006448 cycloalkyl cycloalkyl group Chemical group 0.000 claims 1
- 231100000433 cytotoxic Toxicity 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 230000001472 cytotoxic effect Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 201000005787 hematologic cancer Diseases 0.000 claims 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- 230000001506 immunosuppresive effect Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- UCKQSOIWNOHEFH-UHFFFAOYSA-N methyl 3-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methylamino]benzoate Chemical compound COC(=O)C1=CC=CC(NCC=2C=CC(=CC=2)C=2C=3C=CNC=3N=CC=2)=C1 UCKQSOIWNOHEFH-UHFFFAOYSA-N 0.000 claims 1
- UIENKUKKZRRBSY-UHFFFAOYSA-N methyl 4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=CC=NC2=C1C=CN2 UIENKUKKZRRBSY-UHFFFAOYSA-N 0.000 claims 1
- JJPVQJUMLNOOFA-UHFFFAOYSA-N morpholin-4-yl-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanone Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1C(=O)N1CCOCC1 JJPVQJUMLNOOFA-UHFFFAOYSA-N 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- OJTONPYQFUEPFK-UHFFFAOYSA-N n',n'-dimethyl-n-[[5-(1h-pyrrolo[2,3-b]pyridin-4-yl)furan-2-yl]methyl]ethane-1,2-diamine Chemical compound O1C(CNCCN(C)C)=CC=C1C1=CC=NC2=C1C=CN2 OJTONPYQFUEPFK-UHFFFAOYSA-N 0.000 claims 1
- PUCWNSUDOMOBNX-UHFFFAOYSA-N n,1-dimethyl-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]piperidin-4-amine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CN(C)C1CCN(C)CC1 PUCWNSUDOMOBNX-UHFFFAOYSA-N 0.000 claims 1
- IDOYLBQFDVFJFG-UHFFFAOYSA-N n,n-dimethyl-2-[4-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]piperazin-1-yl]ethanamine Chemical compound C1CN(CCN(C)C)CCN1CC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 IDOYLBQFDVFJFG-UHFFFAOYSA-N 0.000 claims 1
- CLRWZZQFBQZQSR-UHFFFAOYSA-N n,n-dimethyl-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)aniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=NC2=C1C=CN2 CLRWZZQFBQZQSR-UHFFFAOYSA-N 0.000 claims 1
- YAIXIWGAQYBCKV-UHFFFAOYSA-N n,n-dimethyl-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1C1=CC=NC2=C1C=CN2 YAIXIWGAQYBCKV-UHFFFAOYSA-N 0.000 claims 1
- BAVUDFIWZJGWJT-UHFFFAOYSA-N n,n-dimethyl-4-[[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methylamino]methyl]aniline Chemical compound C1=CC(N(C)C)=CC=C1CNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 BAVUDFIWZJGWJT-UHFFFAOYSA-N 0.000 claims 1
- SIICNEXCOAPBHO-UHFFFAOYSA-N n-(2,3-dihydroxypropyl)-3-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound OCC(O)CNC(=O)C1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 SIICNEXCOAPBHO-UHFFFAOYSA-N 0.000 claims 1
- WUOBODXDKBNPCP-UHFFFAOYSA-N n-(2-amino-2-oxoethyl)-3-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound NC(=O)CNC(=O)C1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 WUOBODXDKBNPCP-UHFFFAOYSA-N 0.000 claims 1
- VAPKPKVMFNHWHZ-UHFFFAOYSA-N n-(4-fluorophenyl)-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C1=CC(F)=CC=C1NC(=O)C1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 VAPKPKVMFNHWHZ-UHFFFAOYSA-N 0.000 claims 1
- LLUIHXVYAXKGDO-UHFFFAOYSA-N n-(pyridin-2-ylmethyl)-1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CNCC1=CC=CC=N1 LLUIHXVYAXKGDO-UHFFFAOYSA-N 0.000 claims 1
- KMMIYAJRKFDVJE-UHFFFAOYSA-N n-(pyridin-2-ylmethyl)-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1C(=O)NCC1=CC=CC=N1 KMMIYAJRKFDVJE-UHFFFAOYSA-N 0.000 claims 1
- IFKNPSICEVSZHE-UHFFFAOYSA-N n-(pyridin-3-ylmethyl)-1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CNCC1=CC=CN=C1 IFKNPSICEVSZHE-UHFFFAOYSA-N 0.000 claims 1
- OXUSFSHOXUORDG-UHFFFAOYSA-N n-(pyridin-3-ylmethyl)-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1C(=O)NCC1=CC=CN=C1 OXUSFSHOXUORDG-UHFFFAOYSA-N 0.000 claims 1
- NKKLLOJKVMADHW-UHFFFAOYSA-N n-(pyridin-4-ylmethyl)-1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CNCC1=CC=NC=C1 NKKLLOJKVMADHW-UHFFFAOYSA-N 0.000 claims 1
- GQVCNQNWCBXEJH-UHFFFAOYSA-N n-(pyridin-4-ylmethyl)-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1C(=O)NCC1=CC=NC=C1 GQVCNQNWCBXEJH-UHFFFAOYSA-N 0.000 claims 1
- OQOPWGMTIIOQDU-UHFFFAOYSA-N n-(pyridin-4-ylmethyl)-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]ethanamine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CN(CC)CC1=CC=NC=C1 OQOPWGMTIIOQDU-UHFFFAOYSA-N 0.000 claims 1
- OPFVHECPHAPMTN-UHFFFAOYSA-N n-[(2,4-difluorophenyl)methyl]-1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound FC1=CC(F)=CC=C1CNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 OPFVHECPHAPMTN-UHFFFAOYSA-N 0.000 claims 1
- FHOAMJPDTDXDHN-UHFFFAOYSA-N n-[(2,6-dichlorophenyl)methyl]-1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound ClC1=CC=CC(Cl)=C1CNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 FHOAMJPDTDXDHN-UHFFFAOYSA-N 0.000 claims 1
- NFEJYZHCVITCPB-UHFFFAOYSA-N n-[(2-bromophenyl)methyl]-1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound BrC1=CC=CC=C1CNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 NFEJYZHCVITCPB-UHFFFAOYSA-N 0.000 claims 1
- XQRWXJBRNFNOHS-UHFFFAOYSA-N n-[(2-chlorophenyl)methyl]-1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound ClC1=CC=CC=C1CNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 XQRWXJBRNFNOHS-UHFFFAOYSA-N 0.000 claims 1
- UIZWEWQPOOKKLN-UHFFFAOYSA-N n-[(2-fluorophenyl)methyl]-1-[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound FC1=CC=CC=C1CNCC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 UIZWEWQPOOKKLN-UHFFFAOYSA-N 0.000 claims 1
- XUIUXXQVHPEQNM-UHFFFAOYSA-N n-[(2-fluorophenyl)methyl]-1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound FC1=CC=CC=C1CNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 XUIUXXQVHPEQNM-UHFFFAOYSA-N 0.000 claims 1
- VSFHSIQLKUBNAY-UHFFFAOYSA-N n-[(2-fluorophenyl)methyl]-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound FC1=CC=CC=C1CNC(=O)C1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 VSFHSIQLKUBNAY-UHFFFAOYSA-N 0.000 claims 1
- ILNNFNLWNIEYDB-UHFFFAOYSA-N n-[(2-fluorophenyl)methyl]-n-methyl-1-[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound C=1C=CC(C=2C=3C=CNC=3N=CC=2)=CC=1CN(C)CC1=CC=CC=C1F ILNNFNLWNIEYDB-UHFFFAOYSA-N 0.000 claims 1
- WQEMMQYBABGANL-UHFFFAOYSA-N n-[(2-fluorophenyl)methyl]-n-methyl-1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CN(C)CC1=CC=CC=C1F WQEMMQYBABGANL-UHFFFAOYSA-N 0.000 claims 1
- ZZEFFMSKXSMLJJ-UHFFFAOYSA-N n-[(2-methoxyphenyl)methyl]-1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound COC1=CC=CC=C1CNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 ZZEFFMSKXSMLJJ-UHFFFAOYSA-N 0.000 claims 1
- ZGWLQKNYTYAPJS-UHFFFAOYSA-N n-[(3-fluorophenyl)methyl]-1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound FC1=CC=CC(CNCC=2C=CC(=CC=2)C=2C=3C=CNC=3N=CC=2)=C1 ZGWLQKNYTYAPJS-UHFFFAOYSA-N 0.000 claims 1
- DKCKGZYGDCVOAB-UHFFFAOYSA-N n-[(3-fluorophenyl)methyl]-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound FC1=CC=CC(CNC(=O)C=2C=CC(=CC=2)C=2C=3C=CNC=3N=CC=2)=C1 DKCKGZYGDCVOAB-UHFFFAOYSA-N 0.000 claims 1
- VGIBSSLPENZSQN-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound C1=CC(Cl)=CC=C1CNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 VGIBSSLPENZSQN-UHFFFAOYSA-N 0.000 claims 1
- RRDGHRGOSRCFJT-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-1-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanamine Chemical compound C1=CC(F)=CC=C1CNCC1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 RRDGHRGOSRCFJT-UHFFFAOYSA-N 0.000 claims 1
- QOTZWWCJRNISMJ-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C1=CC(F)=CC=C1CNC(=O)C1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 QOTZWWCJRNISMJ-UHFFFAOYSA-N 0.000 claims 1
- NPLQGCONJZKAKS-UHFFFAOYSA-N n-[2-(1h-imidazol-5-yl)ethyl]-3-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C=1C=CC(C=2C=3C=CNC=3N=CC=2)=CC=1C(=O)NCCC1=CNC=N1 NPLQGCONJZKAKS-UHFFFAOYSA-N 0.000 claims 1
- SEDQCRMWPZSILA-UHFFFAOYSA-N n-[2-(4-fluorophenyl)ethyl]-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C1=CC(F)=CC=C1CCNC(=O)C1=CC=C(C=2C=3C=CNC=3N=CC=2)C=C1 SEDQCRMWPZSILA-UHFFFAOYSA-N 0.000 claims 1
- RPRLEGMLERCGLY-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-3-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound CN(C)CCNC(=O)C1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 RPRLEGMLERCGLY-UHFFFAOYSA-N 0.000 claims 1
- BYWMDXJKSPNUOT-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C1=CC(C(=O)NCCN(C)C)=CC=C1C1=CC=NC2=C1C=CN2 BYWMDXJKSPNUOT-UHFFFAOYSA-N 0.000 claims 1
- BEAMYRWSZGFYDA-UHFFFAOYSA-N n-[3-(2-oxopyrrolidin-1-yl)propyl]-3-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C=1C=CC(C=2C=3C=CNC=3N=CC=2)=CC=1C(=O)NCCCN1CCCC1=O BEAMYRWSZGFYDA-UHFFFAOYSA-N 0.000 claims 1
- PEMRLJYXXVGIHR-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]-3-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound CN(C)CCCNC(=O)C1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 PEMRLJYXXVGIHR-UHFFFAOYSA-N 0.000 claims 1
- QEUXBJNLUFUYRA-UHFFFAOYSA-N n-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1C1=CC=NC2=C1C=CN2 QEUXBJNLUFUYRA-UHFFFAOYSA-N 0.000 claims 1
- HFQGJSOHLRSYET-UHFFFAOYSA-N n-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]benzamide Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1NC(=O)C1=CC=CC=C1 HFQGJSOHLRSYET-UHFFFAOYSA-N 0.000 claims 1
- KPGROIGZSPZUGW-UHFFFAOYSA-N n-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]pyrrolidine-2-carboxamide Chemical compound C=1C=CC(C=2C=3C=CNC=3N=CC=2)=CC=1CNC(=O)C1CCCN1 KPGROIGZSPZUGW-UHFFFAOYSA-N 0.000 claims 1
- YBPFJSMEPPOJKY-UHFFFAOYSA-N n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]-2h-benzotriazol-5-amine Chemical compound C=1C=C2NN=NC2=CC=1NCC(C=C1)=CC=C1C1=CC=NC2=C1C=CN2 YBPFJSMEPPOJKY-UHFFFAOYSA-N 0.000 claims 1
- IFMGHQLFXCZIPH-UHFFFAOYSA-N n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]benzamide Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CNC(=O)C1=CC=CC=C1 IFMGHQLFXCZIPH-UHFFFAOYSA-N 0.000 claims 1
- IWSJDKPOXSMFKM-UHFFFAOYSA-N n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]cyclopentanamine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CNC1CCCC1 IWSJDKPOXSMFKM-UHFFFAOYSA-N 0.000 claims 1
- CLQRNXDOBGJWMO-UHFFFAOYSA-N n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]ethanamine Chemical compound C1=CC(CNCC)=CC=C1C1=CC=NC2=C1C=CN2 CLQRNXDOBGJWMO-UHFFFAOYSA-N 0.000 claims 1
- GCRKEQFSZPLKQR-UHFFFAOYSA-N n-[[5-(1h-pyrrolo[2,3-b]pyridin-4-yl)furan-2-yl]methyl]aniline Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)OC=1CNC1=CC=CC=C1 GCRKEQFSZPLKQR-UHFFFAOYSA-N 0.000 claims 1
- SZTQETXPUPKFDC-UHFFFAOYSA-N n-[[5-(1h-pyrrolo[2,3-b]pyridin-4-yl)thiophen-2-yl]methyl]isoquinolin-5-amine Chemical compound C=1C=CC2=CN=CC=C2C=1NCC(S1)=CC=C1C1=CC=NC2=C1C=CN2 SZTQETXPUPKFDC-UHFFFAOYSA-N 0.000 claims 1
- WQLJYKCVXDRTSA-UHFFFAOYSA-N n-benzyl-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1C(=O)NCC1=CC=CC=C1 WQLJYKCVXDRTSA-UHFFFAOYSA-N 0.000 claims 1
- SZTOFDPTVPMTCS-UHFFFAOYSA-N n-cyclohexyl-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1C(=O)NC1CCCCC1 SZTOFDPTVPMTCS-UHFFFAOYSA-N 0.000 claims 1
- TVDGADGRHFSEFF-UHFFFAOYSA-N n-ethyl-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C1=CC(C(=O)NCC)=CC=C1C1=CC=NC2=C1C=CN2 TVDGADGRHFSEFF-UHFFFAOYSA-N 0.000 claims 1
- GMJDYXBSDPZXHN-UHFFFAOYSA-N n-ethyl-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]ethanamine Chemical compound C1=CC(CN(CC)CC)=CC=C1C1=CC=NC2=C1C=CN2 GMJDYXBSDPZXHN-UHFFFAOYSA-N 0.000 claims 1
- LVVXWPYRFQZKIQ-UHFFFAOYSA-N n-methoxy-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C1=CC(C(=O)NOC)=CC=C1C1=CC=NC2=C1C=CN2 LVVXWPYRFQZKIQ-UHFFFAOYSA-N 0.000 claims 1
- RSHGGEWWLUJDDR-UHFFFAOYSA-N n-methyl-2-pyridin-2-yl-n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]ethanamine Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1CN(C)CCC1=CC=CC=N1 RSHGGEWWLUJDDR-UHFFFAOYSA-N 0.000 claims 1
- XXISXRBDAPWWTF-UHFFFAOYSA-N n-methyl-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=CC=NC2=C1C=CN2 XXISXRBDAPWWTF-UHFFFAOYSA-N 0.000 claims 1
- MQRQAMBUVXMCFW-UHFFFAOYSA-N n-phenyl-4-(1h-pyrrolo[2,3-b]pyridin-4-yl)benzamide Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1C(=O)NC1=CC=CC=C1 MQRQAMBUVXMCFW-UHFFFAOYSA-N 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- DKNDUAPEMZKDGS-UHFFFAOYSA-N piperidin-1-yl-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanone Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1C(=O)N1CCCCC1 DKNDUAPEMZKDGS-UHFFFAOYSA-N 0.000 claims 1
- LUCFQQRSTMLNCA-UHFFFAOYSA-N pyrrolidin-1-yl-[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methanone Chemical compound C=1C=C(C=2C=3C=CNC=3N=CC=2)C=CC=1C(=O)N1CCCC1 LUCFQQRSTMLNCA-UHFFFAOYSA-N 0.000 claims 1
- 208000015347 renal cell adenocarcinoma Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- VWFUKPXNNAEHKC-UHFFFAOYSA-N tert-butyl 4-(1h-pyrrolo[2,3-b]pyridin-4-yl)-3,6-dihydro-2h-pyridine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC(C=2C=3C=CNC=3N=CC=2)=C1 VWFUKPXNNAEHKC-UHFFFAOYSA-N 0.000 claims 1
- IHGARMKOFZGDLP-UHFFFAOYSA-N tert-butyl n-[3-oxo-3-[[3-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methylamino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCC(=O)NCC1=CC=CC(C=2C=3C=CNC=3N=CC=2)=C1 IHGARMKOFZGDLP-UHFFFAOYSA-N 0.000 claims 1
- SJPGGLKQQVIWJB-UHFFFAOYSA-N tert-butyl n-[[4-(1h-pyrrolo[2,3-b]pyridin-4-yl)phenyl]methyl]carbamate Chemical compound C1=CC(CNC(=O)OC(C)(C)C)=CC=C1C1=CC=NC2=C1C=CN2 SJPGGLKQQVIWJB-UHFFFAOYSA-N 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76012406P | 2006-01-19 | 2006-01-19 | |
| PCT/US2007/001439 WO2007084667A2 (en) | 2006-01-19 | 2007-01-18 | Fused heterobicyclic kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009523812A JP2009523812A (ja) | 2009-06-25 |
| JP2009523812A5 true JP2009523812A5 (enExample) | 2010-03-18 |
Family
ID=38180664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008551416A Pending JP2009523812A (ja) | 2006-01-19 | 2007-01-18 | 融合へテロ二環式キナーゼ阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070208053A1 (enExample) |
| EP (1) | EP1979353A2 (enExample) |
| JP (1) | JP2009523812A (enExample) |
| AR (1) | AR059098A1 (enExample) |
| CA (1) | CA2635899A1 (enExample) |
| TW (1) | TW200738709A (enExample) |
| WO (1) | WO2007084667A2 (enExample) |
Families Citing this family (95)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY179032A (en) | 2004-10-25 | 2020-10-26 | Cancer Research Tech Ltd | Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors |
| NZ564065A (en) * | 2005-05-20 | 2011-03-31 | Vertex Pharma | Pyrrolopyridines useful as inhibitors of protein kinase |
| TWI630207B (zh) | 2005-12-13 | 2018-07-21 | 英塞特控股公司 | 作為傑納斯激酶（ＪＡＮＵＳ ＫＩＮＡＳＥ）抑制劑之經雜芳基取代之吡咯并〔２，３-ｂ〕吡啶及吡咯并〔２，３-ｂ〕嘧啶 |
| WO2007125321A2 (en) | 2006-04-25 | 2007-11-08 | Astex Therapeutics Limited | Purine and deazapurine derivatives as pharmaceutical compounds |
| US8604031B2 (en) * | 2006-05-18 | 2013-12-10 | Mannkind Corporation | Intracellular kinase inhibitors |
| MX2009000286A (es) | 2006-06-26 | 2009-03-20 | Procter & Gamble | Inhibidores de prolil hidroxilasa y metodos de uso. |
| DE102006033140A1 (de) * | 2006-07-18 | 2008-01-24 | Merck Patent Gmbh | Aminoindazolharnstoffderivate |
| GB0617161D0 (en) * | 2006-08-31 | 2006-10-11 | Vernalis R&D Ltd | Enzyme inhibitors |
| EP2099774A4 (en) * | 2006-11-15 | 2010-11-24 | Ym Biosciences Australia Pty L | INHIBITORS OF KINASEACTIVITY |
| AR064416A1 (es) * | 2006-12-21 | 2009-04-01 | Cancer Rec Tech Ltd | Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas. |
| EP3070090B1 (en) | 2007-06-13 | 2018-12-12 | Incyte Holdings Corporation | Use of salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3- cyclopentylpropanenitrile |
| AU2008309383B2 (en) | 2007-10-11 | 2012-04-19 | Astrazeneca Ab | Pyrrolo [2, 3 -D] pyrimidin derivatives as protein kinase B inhibitors |
| CA2704266A1 (en) | 2007-11-02 | 2009-06-11 | Vertex Pharmaceuticals Incorporated | [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta |
| WO2009075874A1 (en) * | 2007-12-13 | 2009-06-18 | Amgen Inc. | Gamma secretase modulators |
| CN101918079A (zh) * | 2008-01-22 | 2010-12-15 | 默克专利有限公司 | 蛋白激酶抑制剂及其用途 |
| CN101959404B (zh) | 2008-02-04 | 2015-12-02 | 墨丘瑞医疗有限公司 | 单磷酸腺苷活化蛋白激酶调节剂 |
| KR100979439B1 (ko) * | 2008-04-10 | 2010-09-02 | 한국화학연구원 | 신규 피라졸 및 벤즈옥사졸 치환된 피리딘 유도체 또는이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를유효성분으로 함유하는 이상세포 성장 질환의 예방 및치료용 약학적 조성물 |
| AR071717A1 (es) | 2008-05-13 | 2010-07-07 | Array Biopharma Inc | Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer. |
| CL2009001884A1 (es) * | 2008-10-02 | 2010-05-14 | Incyte Holdings Corp | Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco. |
| EP3643312A1 (en) | 2009-05-22 | 2020-04-29 | Incyte Holdings Corporation | 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors |
| AR076794A1 (es) | 2009-05-22 | 2011-07-06 | Incyte Corp | Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo [2,3-d]pirimidinas y pirrol-3-il-pirrolo [2,3-d ]pirimidinas como inhibidores de la quinasa janus y composiciones farmaceuticas que los contienen |
| TWI466885B (zh) | 2009-07-31 | 2015-01-01 | Japan Tobacco Inc | 含氮螺環化合物及其醫藥用途 |
| JP5746172B2 (ja) | 2009-08-20 | 2015-07-08 | カルス セラピューティクス リミテッド | ホスホイノシチド３−キナーゼ阻害剤としての三環式複素環化合物 |
| AR078012A1 (es) | 2009-09-01 | 2011-10-05 | Incyte Corp | Derivados heterociclicos de las pirazol-4-il- pirrolo (2,3-d) pirimidinas como inhibidores de la quinasa janus |
| EP2485731B1 (en) * | 2009-10-06 | 2016-05-11 | Millennium Pharmaceuticals, Inc. | Heterocyclic compounds useful as pdk1 inhibitors |
| CN102844317B (zh) * | 2010-02-18 | 2015-06-03 | 因西特公司 | 作为Janus激酶抑制剂的环丁烷和甲基环丁烷衍生物 |
| EP3050882B1 (en) | 2010-03-10 | 2018-01-31 | Incyte Holdings Corporation | Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| US8324239B2 (en) | 2010-04-21 | 2012-12-04 | Novartis Ag | Furopyridine compounds and uses thereof |
| SG10201503983QA (en) | 2010-05-21 | 2015-06-29 | Incyte Corp | Topical Formulation for a JAK Inhibitor |
| CN103415515B (zh) | 2010-11-19 | 2015-08-26 | 因塞特公司 | 作为jak抑制剂的环丁基取代的吡咯并吡啶和吡咯并嘧啶衍生物 |
| US9034884B2 (en) | 2010-11-19 | 2015-05-19 | Incyte Corporation | Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors |
| ES2547916T3 (es) | 2011-02-18 | 2015-10-09 | Novartis Pharma Ag | Terapia de combinación de inhibidores de mTOR/JAK |
| BR112013025410A2 (pt) | 2011-04-01 | 2016-12-20 | Astrazeneca Ab | tratamento terapêutico |
| NO2686520T3 (enExample) | 2011-06-06 | 2018-03-17 | ||
| MX2013014310A (es) | 2011-06-06 | 2014-01-23 | Akebia Therapeutics Inc | Compuestos y composiciones para estabilizar el factor-2 alfa inducible por hipoxia como un metodo para tratar el cancer. |
| PE20140832A1 (es) | 2011-06-20 | 2014-07-14 | Incyte Corp | Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak |
| WO2013008095A1 (en) | 2011-07-08 | 2013-01-17 | Novartis Ag | Novel pyrrolo pyrimidine derivatives |
| HK1198579A1 (en) | 2011-08-10 | 2015-04-30 | Novartis Pharma Ag | Jak p13k/mtor combination therapy |
| TW201313721A (zh) | 2011-08-18 | 2013-04-01 | Incyte Corp | 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物 |
| UA111854C2 (uk) | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
| CA2856646C (en) | 2011-11-30 | 2020-01-14 | Astrazeneca Ab | Combination treatment of cancer |
| ES2567552T3 (es) * | 2012-01-30 | 2016-04-25 | Cephalon, Inc. | Imidazo [4,5-b] derivados de piridina como los moduladores ALK y JAK para el tratamiento de trastornos proliferativos |
| GB201204125D0 (en) | 2012-03-08 | 2012-04-25 | Karus Therapeutics Ltd | Compounds |
| AU2013204533B2 (en) | 2012-04-17 | 2017-02-02 | Astrazeneca Ab | Crystalline forms |
| TW201406761A (zh) | 2012-05-18 | 2014-02-16 | Incyte Corp | 做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物 |
| AU2013343291B2 (en) | 2012-11-07 | 2018-05-10 | Karus Therapeutics Ltd | Novel histone deacetylase inhibitors and their use in therapy |
| PL2919766T3 (pl) | 2012-11-15 | 2021-10-04 | Incyte Holdings Corporation | Postacie dawkowania ruksolitynibu o przedłużonym uwalnianiu |
| US9260426B2 (en) | 2012-12-14 | 2016-02-16 | Arrien Pharmaceuticals Llc | Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors |
| WO2014138212A1 (en) * | 2013-03-06 | 2014-09-12 | Allosteros Therapeutics, Inc. | CaMKII INHIBITORS AND USES THEREOF |
| CN105189509B (zh) | 2013-03-06 | 2017-12-19 | 因赛特公司 | 用于制备jak抑制剂的方法及中间体 |
| TW201533043A (zh) * | 2013-04-18 | 2015-09-01 | Lundbeck & Co As H | 作爲ｌｒｒｋ２抑制劑的芳基吡咯并吡啶衍生化合物 |
| EP2994465B1 (en) | 2013-05-10 | 2018-08-15 | Karus Therapeutics Limited | Novel histone deacetylase inhibitors |
| CN114404414A (zh) | 2013-06-13 | 2022-04-29 | 阿克比治疗有限公司 | 用于治疗贫血症的组合物和方法 |
| SG10201912203XA (en) | 2013-08-07 | 2020-02-27 | Incyte Corp | Sustained release dosage forms for a jak1 inhibitor |
| GB201317363D0 (en) | 2013-10-01 | 2013-11-13 | Eisai Ltd | Novel compounds |
| KR102495018B1 (ko) | 2013-11-15 | 2023-02-06 | 아케비아 테라퓨틱스 인코포레이티드 | ｛[5-(3-클로로페닐)-3-하이드록시피리딘-2-카보닐]아미노｝아세트산의 고체형, 이의 조성물 및 용도 |
| EP3080122B1 (en) * | 2013-12-11 | 2018-10-31 | Biogen MA Inc. | Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology |
| GB201402431D0 (en) | 2014-02-12 | 2014-03-26 | Karus Therapeutics Ltd | Compounds |
| WO2015184305A1 (en) | 2014-05-30 | 2015-12-03 | Incyte Corporation | TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1 |
| US10112939B2 (en) | 2014-08-21 | 2018-10-30 | Bristol-Myers Squibb Company | Tied-back benzamide derivatives as potent rock inhibitors |
| WO2016037106A1 (en) | 2014-09-05 | 2016-03-10 | Allosteros Therapeutics, Inc | CaMKII INHIBITORS AND USES THEREOF |
| GB201419228D0 (en) | 2014-10-29 | 2014-12-10 | Karus Therapeutics Ltd | Compounds |
| GB201419264D0 (en) | 2014-10-29 | 2014-12-10 | Karus Therapeutics Ltd | Compounds |
| EP3247355A4 (en) | 2015-01-23 | 2018-06-13 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
| EA036920B1 (ru) | 2015-04-01 | 2021-01-15 | Экебиа Терапьютикс, Инк. | Композиции и способы для лечения анемии |
| GB201514751D0 (en) | 2015-08-19 | 2015-09-30 | Karus Therapeutics Ltd | Compounds |
| GB201514754D0 (en) | 2015-08-19 | 2015-09-30 | Karus Therapeutics Ltd | Compounds |
| GB201514758D0 (en) | 2015-08-19 | 2015-09-30 | Karus Therapeutics Ltd | Formulation |
| GB201514760D0 (en) | 2015-08-19 | 2015-09-30 | Karus Therapeutics Ltd | Compounds and method of use |
| US11414413B2 (en) | 2016-07-26 | 2022-08-16 | Suzhou Longbiotech Pharmaceuticals Co., Ltd. | Heterocyclic compound as JAK inhibitor, and salts and therapeutic use thereof |
| EA039352B1 (ru) * | 2017-01-19 | 2022-01-17 | Сучжоу Лонгбайотек Фармасьютикалз Ко., Лтд. | Соединение в качестве селективного ингибитора jak и его соли и терапевтическое применение |
| US11168082B2 (en) * | 2017-05-15 | 2021-11-09 | The Regents Of The University Of Michigan | Pyrrolo[2,3-C]pyridines and related analogs as LSD-1 inhibitors |
| US11547712B2 (en) | 2017-11-20 | 2023-01-10 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
| WO2019113487A1 (en) | 2017-12-08 | 2019-06-13 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
| CN111819193A (zh) | 2018-01-05 | 2020-10-23 | 西奈山伊坎医学院 | 增加胰腺β细胞增殖的方法、治疗方法以及组合物 |
| EP3746429B1 (en) | 2018-01-30 | 2022-03-09 | Incyte Corporation | Processes for preparing (1-(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one) |
| AU2019240065A1 (en) | 2018-03-20 | 2020-09-24 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
| PT3773593T (pt) | 2018-03-30 | 2024-06-25 | Incyte Corp | Tratamento da hidradenite supurativa com inibidores de jak |
| JP7187575B2 (ja) | 2018-04-18 | 2022-12-12 | メッドシャイン ディスカバリー インコーポレイテッド | Ｒｈｏキナーゼ阻害剤としてのベンゾピラゾール系化合物 |
| TW202406895A (zh) | 2018-05-09 | 2024-02-16 | 美商阿克比治療有限公司 | 用於製備2-[[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基]乙酸之方法 |
| JP2022515652A (ja) * | 2018-12-31 | 2022-02-21 | アイカーン スクール オブ メディシン アット マウント サイナイ | キナーゼ阻害剤化合物及び組成物ならびに使用方法 |
| US20220324880A1 (en) * | 2019-06-10 | 2022-10-13 | Kymara Therapeutics, Inc. | Smarca inhibitors and uses thereof |
| GB201909468D0 (en) | 2019-07-01 | 2019-08-14 | Karus Therapeutics Ltd | Compounds for treating cancer |
| US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
| IL321884A (en) * | 2020-02-07 | 2025-09-01 | Cytokinetics Inc | Nampat modulators |
| TWI794742B (zh) | 2020-02-18 | 2023-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| EP4106876B1 (en) | 2020-02-18 | 2025-09-17 | Gilead Sciences, Inc. | Antiviral compounds |
| TWI874791B (zh) | 2020-02-18 | 2025-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
| WO2022165402A1 (en) * | 2021-02-01 | 2022-08-04 | Blueprint Medicines Corporation | Inhibitors of protein kinase a |
| KR102923359B1 (ko) | 2021-04-16 | 2026-02-05 | 길리애드 사이언시즈, 인코포레이티드 | 아미드를 사용한 카르바뉴클레오시드를 제조하는 방법 |
| KR102635126B1 (ko) * | 2021-05-27 | 2024-02-13 | 한국과학기술연구원 | 엑토뉴클레오티드 피로포스파타아제-포스포디에스터라아제의 저해 활성을 갖는 신규한 피롤로피리미딘 유도체 및 이들의 용도 |
| EP4387977A1 (en) | 2021-08-18 | 2024-06-26 | Gilead Sciences, Inc. | Phospholipid compounds and methods of making and using the same |
| US20250361230A1 (en) * | 2022-06-06 | 2025-11-27 | The USA, as Represented by the Secretary, Dept. of Heath and Human Services | LATS Inhibitors and Uses Thereof |
| AU2023387127A1 (en) * | 2022-11-25 | 2025-06-19 | Xenolis Pte. Ltd. | Nucleic acid aptamer |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB915304A (en) * | 1958-03-13 | 1963-01-09 | Wellcome Found | Pyrrolo[2,3-d]pyrimidine derivatives |
| DE4022414A1 (de) * | 1990-07-13 | 1992-01-16 | Bayer Ag | Substituierte pyrrolo-pyridine |
| WO2001047922A2 (en) * | 1999-12-24 | 2001-07-05 | Aventis Pharma Limited | Azaindoles |
| SE0301372D0 (sv) * | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | Novel compounds |
| US7340723B2 (en) * | 2003-07-02 | 2008-03-04 | Scaleform Corporation | Identifier implementation mapping and methods of using namespaces |
| CN1925855B (zh) * | 2003-12-19 | 2010-06-16 | 普莱希科公司 | 开发Ret调节剂的化合物和方法 |
| NZ584499A (en) * | 2004-03-30 | 2011-08-26 | Vertex Pharma | Azaindoles Useful as Inhibitors of Jak and Other Protein Kinases |
| MY179032A (en) * | 2004-10-25 | 2020-10-26 | Cancer Research Tech Ltd | Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors |
| UY29177A1 (es) * | 2004-10-25 | 2006-05-31 | Astex Therapeutics Ltd | Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos |
| MX2007014377A (es) * | 2005-05-17 | 2008-02-06 | Plexxikon Inc | Inhibidores de proteina cinasa de derivados de pirrol (2,3-b) piridina. |
| NZ564065A (en) * | 2005-05-20 | 2011-03-31 | Vertex Pharma | Pyrrolopyridines useful as inhibitors of protein kinase |
| PL2395004T3 (pl) * | 2005-06-22 | 2016-08-31 | Plexxikon Inc | Pochodne pirolo[2,3-b]pirydyny jako inhibitory kinazy białkowej |
| JP2009521490A (ja) * | 2005-12-22 | 2009-06-04 | スミスクライン ビーチャム コーポレーション | 化合物 |
-
2007
- 2007-01-18 US US11/654,814 patent/US20070208053A1/en not_active Abandoned
- 2007-01-18 WO PCT/US2007/001439 patent/WO2007084667A2/en not_active Ceased
- 2007-01-18 EP EP07718344A patent/EP1979353A2/en not_active Withdrawn
- 2007-01-18 TW TW096101975A patent/TW200738709A/zh unknown
- 2007-01-18 CA CA002635899A patent/CA2635899A1/en not_active Abandoned
- 2007-01-18 JP JP2008551416A patent/JP2009523812A/ja active Pending
- 2007-01-19 AR ARP070100248A patent/AR059098A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009523812A5 (enExample) | ||
| ES2611588T3 (es) | Pirrolo[2,3-b]piridinas y pirrolo[2,3-b]pirimidinas sustituidas con heteroarilo como inhibidores de quinasas Janus | |
| RU2015139590A (ru) | ИНГИБИРУЮЩЕЕ Trk СОЕДИНЕНИЕ | |
| RU2573834C2 (ru) | ФАРМАЦЕВТИЧЕСКИ АКТИВНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Axl | |
| RU2326881C9 (ru) | Конденсированные производные азолпиримидина, обладающие свойствами ингибитора фосфатидилинозитол-3-киназы (pi3k) | |
| JP4988355B2 (ja) | 置換ピペラジン | |
| NZ591427A (en) | P38 map kinase inhibitors | |
| JP2003528810A5 (enExample) | ||
| RU2019120990A (ru) | Бициклические гетероарильные производные в качестве стимуляторов cftr | |
| JP2019038839A (ja) | 新規の二環式ブロモドメイン阻害剤 | |
| RU2009148673A (ru) | Производные пиразинона и их применение для лечения легочных заболеваний | |
| HRP20150642T1 (hr) | BICIKLIÄŚKE HETEROCIKLIÄŚKE TVARI KAO INHIBITORI FGFR-a | |
| Rossi et al. | Direct (hetero) arylation reactions of (hetero) arenes as tools for the step-and atom-economical synthesis of biologically active unnatural compounds including pharmaceutical targets | |
| JP2009534471A5 (enExample) | ||
| ES2244752T3 (es) | Derivados de imidazo-pirimidina como ligandos para receptores de gaba. | |
| NZ579833A (en) | 7-substituted indole mcl-1 inhibitors | |
| JP2012515787A5 (enExample) | ||
| JP2013521286A5 (enExample) | ||
| JP2008540574A5 (enExample) | ||
| JPWO2021170109A5 (enExample) | ||
| JP2010513435A5 (enExample) | ||
| CA2628844A1 (en) | Pyrazole derivatives and their medical use | |
| Marinozzi et al. | N-Aryl-5-aminopyrazole: a versatile architecture in medicinal chemistry | |
| JP2013502441A5 (enExample) | ||
| US20120283273A1 (en) | Indole and azaindole modulators of the alpha 7 nachr |